Alembic Limited (ALEMBICLTD) Share Price
NSE · Real Estate · Real Estate - Development · ISIN INE426A01027
Key metrics
- Market Cap
- ₹2,639 Cr
- P/E Ratio
- 8.23
- EPS
- 12.49
- Book Value
- 95.22
- P/B Ratio
- 1.04
- ROE
- 12.98%
- ROCE
- 3.19%
- Debt / Equity
- 0
- Net Margin
- 138.01%
- Revenue Growth
- 8.9%
- Profit Growth
- 2.16%
- Dividend Yield
- 2.43%
- 52W High
- ₹108.50
- 52W Low
- ₹70.46
- Market Cap Band
- small cap
- Face Value
- 2
Ratios computed from the annual results period ending 2026-03-31.
About Alembic Limited
Alembic Limited engages in real estate business in India and internationally. It operates through Active Pharmaceutical Ingredient (API) and Real Estate segments. The company constructs residential and commercial real estate projects; provides project management and marketing consultancy services; and leases commercial properties. It also manufactures and markets fermentation and chemistry based active pharmaceutical ingredients; and research and development activities. In addition, the company is involved in power generation through co-generation plants and wind power sources. It serves individuals, entrepreneurs, corporates, business houses, HNIs, NRIs, and pharmaceutical companies. The company was incorporated in 1907 and is based in Vadodara, India. Alembic Limited is a subsidiary of Nirayu Pvt. Ltd.
- Headquarters
- Vadodara, India
- Employees
- 261
- Promoter Holding
- 72.42%
The full Alembic Limited analysis
Create a free account to open the complete ALEMBICLTD deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.